Several polymorphisms in the GST omega class have been acknowledged as cancer-risk biomarkers [22,23,24,25], but, to the best of our knowledge, this is the first study investigating the association of GSTO1 polymorphic expression in relation to testicular tumorigenesis [31,32,33,34,35]. The gene discussed is GSTO1; the disease is cancer.